Drug Shortage Report for TEGRETOL CR

Last updated on 2025-03-12 History
Report ID 227205
Drug Identification Number 00773611
Brand name TEGRETOL CR
Common or Proper name TEGRETOL CR 200MG TABS
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) CARBAMAZEPINE
Strength(s) 200MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100'S
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2024-05-08
Actual start date 2024-05-08
Estimated end date 2024-07-18
Actual end date 2024-07-18
Shortage status Resolved
Updated date 2025-03-12
Company comments Product is on allocation to minimize patient impact.
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2025-03-12 English Compare
v20 2024-07-19 French Compare
v19 2024-07-19 English Compare
v18 2024-07-16 French Compare
v17 2024-07-16 English Compare
v16 2024-07-12 French Compare
v15 2024-07-12 English Compare
v14 2024-07-09 French Compare
v13 2024-07-09 English Compare
v12 2024-06-19 French Compare
v11 2024-06-19 English Compare
v10 2024-06-11 French Compare
v9 2024-06-11 English Compare
v8 2024-06-11 English Compare
v7 2024-05-13 English Compare
v6 2024-05-09 English Compare
v5 2024-05-07 French Compare
v4 2024-05-07 English Compare
v3 2024-05-07 French Compare
v2 2024-05-07 English Compare

Showing 1 to 20 of 21